Global intragastric balloon market projected to double by 2031, exceeding USD 1.79 billion as obesity interventions evolve.
[San Diego, 26 June 2025] – The global intragastric balloon market is projected to grow from USD 0.86 billion in 2024 to USD 1.79 billion by 2031, according to Clearview Market Insights (CVMI), achieving a CAGR of 11.0%. Rising global obesity rates and the search for non-surgical weight loss solutions are driving adoption.
“Today’s intragastric balloons offer patients safer, less invasive alternatives to bariatric surgery—faster to deploy and recover from,” said Dr. Fatima Awan, metabolic health analyst at CVMI. “With innovation in delivery systems and growing consumer demand, this market is gaining momentum worldwide.”
Request Sample @ https://clearviewmarketinsights.com/report-details/global-intragastric-balloon-market/
Key Market Stats
- 2024 Market Value: USD 0.86 billion
- 2031 Forecast: USD 1.79 billion
- CAGR: 11.0% (2024–2031)
Growth Drivers
- Medical Weight Loss Trend: Health-conscious consumers opting for non-surgical solutions
- Technology Leap: Swallowable balloons with wireless pressure sensors and smart deflation alerts
- Private Clinics Surge: Especially in Latin America, MENA, and parts of Southeast Asia
Segment Insights
- Top Product: Swallowable saline balloons lead in patient preference
- Fastest-Growing Region: Asia-Pacific, due to urban obesity surge and cost-effective offerings
- Primary Users: Bariatric clinics and ASC-based weight loss programs
Competitive Landscape (2024)
- Allurion – 31%: First-in-class Elipse® system without endoscopy
- Apollo Endosurgery – 27%: Legacy leader in balloon-assisted gastric volume reduction
- Spatz – 15%: Only adjustable balloon system with up to 12-month retention
- Obalon – 9%: Lightweight capsule-based design favored in U.S.
- Others – 18%: Boutique providers in aesthetic medical tourism hotspots
Looking Ahead to 2031
Digital follow-up systems, lifestyle coaching, and integration with virtual care platforms will define the next generation of intragastric balloon therapy. Manufacturers that prioritize comfort, ease of use, and outcome tracking will maintain a long-term competitive advantage.
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369